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High-resolution NMR-based metabolic detection of
microgram biopsies using a 1 mm HRμMAS probe†
Yusuke Nishiyama,a,b Yuki Endo,a Takahiro Nemoto,a Anne-Karine Bouzier-Sorec
and Alan Wong*d
A prototype 1 mm High-Resolution micro-Magic Angle Spinning
(HRμMAS) probe is described. High quality 1H NMR spectra were
obtained from 490 μg of heterogeneous biospecimens, oﬀering a
rich-metabolite proﬁling. The results demonstrate the potential of
HRμMAS as a new NMR analytical tool in metabolomics.
Today 1H HRMAS (High-Resolution Magic-Angle Spinning)
NMR (Nuclear Magnetic Resonance) spectroscopy finds great
success in laboratory studies of the metabolome in hetero-
geneous biospecimens such as human and animal biopsies,1–3
intact cells4 and whole organisms,5,6 owing to the nearly non-
destructive nature of the technique and the straightforward
data acquisition.7 However, since NMR spectroscopy is an
inherently insensitive analytical technique, HRMAS relies on a
large sample mass, typically 10–20 mg per NMR data. For this
reason, 1H HRMAS analysis can be a real challenge (or even
impossible) when samples – such as cells, organisms and
tissue biopsies – are scarce. Moreover, analysis of 10–20 mg of
heterogeneous specimens may prevent the investigation of a
specific cell. In contrast, the high degree of homogeneity
inside a microscopic specimen can oﬀer a more direct NMR
spectral analysis and enable a straightforward metabolic evalu-
ation. The immediate advantages of small sample mass (i.e.
microgram) analyses are: (1) they simplify the sample prep-
arations such as cultivation and extraction; and (2) oﬀer
precise specimen-specific analyses for exploring the invisible
phenotypes.
The most cost-eﬀective approach to microscopic NMR
detection is the use of a miniature detection coil (μcoil). With
this technique, the coil is in close proximity to the microscopic
sample optimizing the filling-factor (the ratio of the sample
volume to the coil detection volume).8 Fabricating a μcoil for
HRMAS analyses is no easy task, especially without sacrificing
detection sensitivity and spectral resolution.9 The commercial
μMAS systems currently available (i.e. 0.7 mm Bruker MAS and
0.75 mm JEOL MAS) are designed for solid materials but do
not oﬀer adequate spectral resolution (0.002 ppm) for meta-
bolic investigations.
Today, the only approach to μMAS for metabolome analyses
is the use of an inductively coupled High-Resolution Magic-
Angle Coil Spinning (HRMACS) μcoil.10 The HRMACS tech-
nique uses a secondary tuned circuit (i.e. μcoil-resonator),
designed to fit inside a standard 4 mm MAS rotor, to convert
the standard large volume MAS system into a high-resolution
capable μMAS probe.11,12 The use of HRMACS has shown
some success in intact cells13 and whole small organisms14 for
the metabolic profiling and diﬀerentiation of microgram bio-
specimens. However, great eﬀorts are required to make and
operate the HRMACS μcoil. For example, manually winding the
μcoil is a strenuous task that requires good micro-engineering
skills and patience; the μcoil is fragile and needs to be
handled with great caution and care. In addition, the sample
spinning frequency of the HRMACS μcoil is limited to 500 Hz
in order to minimize the sample heating,10 which originates
from the eddy current.15 As a result, the isotropic signal is dis-
sipated into the dense spinning-sidebands diminishing the
overall sensitivity. For this reason, special pulse-experiments
(such as PASS) must be applied to acquire sideband-free isotro-
pic spectra.
In this communication we present the first 1 mm high-
resolution μMAS (denoted HRμMAS) NMR probe specially
designed for the analyses of microscopic biospecimens. The
prototype probe is modified from a solid-state μMAS probe. It
features a stationary 10-turn μcoil solenoid 1 mm in diameter
and 1.9 mm in length. The unloaded coil quality factor at
600 MHz is about 150. This value is considerably higher than
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the quality factor of the manually made HRMACS μcoil, i.e.
30–50 at 500 MHz. Samples were packed in Kel-F rotors with
1.0/0.5 mm outer/inner diameters and 6.55 mm length. To
ensure that the sample is inside the detection region, a Kel-F
cap (each about 1.5 mm long) is inserted at each end of the
rotor. The total sample detection volume is about 490 nl (see
Fig. S1 in the ESI†). Using Kel-F rotors, instead of standard
ZrO rotors, eliminates the anisotropic magnetic susceptibility
broadening16 – which cannot be completely averaged under
MAS – caused by ZrO. Another advantage of Kel-F rotors is that
they can be used as disposable rotors because the cost is sub-
stantially lower than ZrO (200 € versus 2000 €). The HRμMAS
probe produces a very good B1 homogeneity over the sample
volume with an intensity ratio I450°/I90° of about 95%; whereas
<80% is found for HRMACS. A comparison of the probe pro-
perties and performances of the HRμMAS prototype and the
existing HRMACS can be found in the ESI.†
To address the question ‘is it possible to construct a μMAS
probe with high spectral resolution and high detection sensi-
tivity that is suitable for 1H NMR-based metabolomics
studies?’ we have modified a JEOL 1 mm solid-state MAS
probe with 1H frequency at 600 MHz. This probe was originally
designed for the ultra-fast sample spinning (up to 80 kHz) of
rigid-solids to achieve a high spectral resolution for solid
materials.17 The optimal spectral resolution is however not
adequate for 1H NMR metabolomics studies. As shown in
Fig. 1a, the 1H NMR spectrum of a 20 mM sucrose solution
displays broad lines in all resonances (FWHM of about
0.01 ppm) that prevent any detailed and precise analyses of the
metabolome in specimens. The observed line-broadenings are
mainly attributed to the large magnetic susceptibility gradients
between the sample and the nearby stationary (non-spinning)
components inside the probe, such as the MAS stator and the
copper-wire. To minimize these gradients, we have changed
the air-bearing inside the MAS stator from Zirconia to Vespel®
and the copper wire μcoil to a susceptibility-matched wire
(copper/aluminum) which has susceptibility similar to air.
These changes result in a drastic improvement of the resolu-
tion that passes from 0.01 ppm (FWHM) to about 0.002 ppm
(Fig. 1a). The small residual broadening in the HRμMAS spec-
trum is attributed to the susceptibility gradient originating
from the leads of the μcoil, which are made of copper wire. We
note that these can be replaced with a copper/aluminum wire
to eliminate the residual broadening. Nonetheless, the spectral
resolution obtained with the HRμMAS probe oﬀers nearly ideal
spectral conditions (superior to the solid-state μMAS probe) for
high-precision metabolic analyses.
One of the reasons why 1H NMR spectroscopy, including 1H
HRMAS, has found great success in metabolomics is because
it provides a stable and repeatable analytical platform. To
evaluate the spectral data repeatability with HRμMAS, 24 con-
secutive spectra of the same 20 mM sucrose solution were
acquired with the following experimental procedures: (1)
manually inserting the Kel-F rotor containing the sample into
the probe head, (2) spinning the sample at 2255 ± 5 Hz,
(3) applying the 2H lock (using the X-channel), (4) acquiring the
1H spectrum, (5) stopping the sample spinning, (6) ejecting
the sample and repeating the above procedures for 24 acqui-
sitions. Fig. 1b shows the obtained 24 spectra and clearly illus-
trates the good stability and data repeatability of the HRμMAS
probe.
Fig. 2 shows four 1D 1H NMR spectra of diﬀerent 490 μg
biospecimens (refer to the ESI† for the sample preparation)
obtained with the HRμMAS probe at 600 MHz and with stable
sample spinning (±5 Hz) between 2000 and 2500 Hz. The
spectra were recorded with a standard t2-edited CMPG pulse-
experiment to suppress signals from the large biomolecules
(i.e. proteins and lipids). The gain in sensitivity from the μcoil
permits short acquisitions. In just 10–30 minutes, the NMR
spectra display a good signal-to-noise ratio (SNR) over the
metabolite-rich 1H chemical shift region (3–4 ppm): 82 for
chicken liver, 38 for pig liver, 32 for brain biopsy and 20 for
brain extract. We note that the aforementioned residual sus-
ceptibility broadening (top spectrum in Fig. 1a) is negligible in
Fig. 2. The combination of good SNR and resolution oﬀers
precise and detailed metabolic profiling. About 25 to 30 meta-
bolites are identified from the spectra, including the low signal
intensities of aromatic metabolites (6–9 ppm). The spectral
profile (i.e. metabolic profile) for each specimen is clearly
diﬀerent from one another. For example, the lipids (1.28 ppm)
Fig. 1 (a) 1H MAS NMR spectral comparison of 490 nl 20 mM sucrose
solution using an unmodiﬁed solid-state 1 mm μMAS probe [bottom]
and the 1 mm HRμMAS probe [top]. (b) Overlay of 24 spectra of sucrose
solution acquired with the HRμMAS. The blue columns represent the
Coeﬃcient of Variant (CV) of each of the chemical shift bucket
(0.005 ppm) intensities (average sum). The CV values can be found in
the ESI.† All spectra are processed without apodization.
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are absent in the brain hydrophilic extracts, whereas a high
content of lipids is found in the pig liver biopsy. A much
higher content of scyllo-inositol (3.35 ppm) is found in the
chicken liver as compared to the pig liver. On the other hand,
a greater content of glucose (5.23 ppm) is found in the pig
liver.
Similar to the standard large volume 4 mm HRMAS probe,
multi-dimensional experiments can be readily performed with
HRμMAS, enhancing the ability of metabolic identification
and annotation. Fig. 3a displays a 2D 1H–1H TOCSY HRμMAS
spectrum of a brain biopsy. The cross-signals in the 2D spec-
trum indicate the presence of glutamate, glutamine, taurine
and myo-inositol. It is noteworthy that 2D TOCSY and COSY
experiments with excellent spectral quality have also been
acquired for the brain extract. These 2D spectra reveal numer-
ous metabolites (see Fig. 2S in the ESI†).
The brain biopsy in Fig. 3a was previously infused with
[3-13C]lactate during the brain simulation by a continuous
whisker movement (1 h).18 Spectral identification of the [3-13C]
lactate and its relevant metabolites using 1H–13C NMR spec-
troscopy, permits the investigation of the lactate metabolisms
in astrocytes in the nervous system. The 2D 1H–13C HMQC
spectrum in Fig. 3b identifies a few metabolites – alanine,
lactate, glutamate, glutamine, γ-aminobutyric acid – associated
with [3-13C]lactate in the lactate metabolisms. These results
are in agreement with the previous HRMAS study18 obtained
using 20–30 mg biopsy for one NMR data. The observed broad
1H signal (∼2 Hz) in HMQC is attributed to the small B0 drift
over the 27 hours of experimental time, since the HMQC spec-
trum was recorded without the 2H-lock. This is because the
X-channel was used for the 13C resonance. Nonetheless, the
results demonstrate that performing double resonance NMR
experiments with the HRμMAS probe is straightforward. Con-
versely, the HRMACS μcoil would need a more elaborate experi-
Fig. 2 1H HRμMAS NMR metabolic proﬁling of four 490 μg bio-
specimens (a) chicken liver, (b) pig liver, (c) rat brain biopsy and (d) rat
brain extract. The inserted spectra are the chemical shift expansions,
2.9–4.5 ppm, which are indicated by a horizontal bar in (d). The spectra
were acquired with a t2-edited CPMG pulse experiment at 600 MHz and
with sample spinning between 2000 and 2500 Hz using a Kel-F rotor.
See the ESI† for more NMR experimental details. The metabolite
assignments are as follows: 1 isoleucine; 2 leucine; 3 valine; 4 lactate;
5 alanine; 6 lysine; 7 γ-aminobutyric acid; 8 acetone; 9 N-acetyl aspartate;
10 glutamate; 11 glutamine; 12 asparagine; 13 creatine; 14 phos-
phocreatine; 15 choline; 16 phosphocholine; 17 glycerophosphocholine;
18 taurine; 19 myo-inositol; 20 scyllo-inositol; 21 glucose; 22 glycerol;
23 tyrosine; 24 phenylalanine; 25 adenosine; 26 adenosine triphosphate;
27 lipids: (a) CH3, (b) –(CH2)n–, (c) –(CH2)nCO, (d) CH2CvC, (e) CH2CO,
(f ) CvCCH2CvC.
Fig. 3 (a) 1H–1H TOCSY and (b) 1H–13C HMQC HRμMAS spectrum of a
[3-13C]lactate infused brain biopsy, demonstrating the feasibility of per-
forming homonuclear and heteronuclear 2D experiments with HRμMAS.
See the ESI† for NMR experimental details.
Analyst Communication









































mental setup.19 Moreover, the fast sample spinning applied
with the HRμMAS probe (2000–2500 Hz) eliminates the side-
band manifold 2D spectra oﬀering cleaner spectral data than
that with the HRMACS.
Conclusions
The 1 mm HRμMAS probe described here is a prototype. It was
modified from a solid-state 1 mm μMAS probe to demonstrate
the possibility of constructing a high resolution and high sensi-
tivity μMAS probe for microgram biospecimen applications in a
convenient, reliable and repeatable manner. The high quality
spectra reported here illustrate the potential of investigating
small quantity biopsies or other biospecimens. Also, new
studies and experiments with the HRμMAS probe can be
explored. For example, HRμMAS could be coupled with micro-
fluidic-based cell (or small organism) sorting and manipulating
techniques for a potent micro-scale NMR screening pipeline;20,21
it could also be used for investigating the metabolic profiles of
scarce specimens (i.e. neurons cells and small diseases tissues),
or exploring the invisible phenotypes of specimens that cannot be
studied with standard large volume HRMAS NMR spectroscopy.
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